{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:42:42Z","timestamp":1773024162986,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jiac.2023.09.030","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:04:46Z","timestamp":1696392286000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: A single-center retrospective study"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0319-5466","authenticated-orcid":false,"given":"Misaki","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Uchitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-3698","authenticated-orcid":false,"given":"Masahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.09.030_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.09.030_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10156-012-0453-0","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies","volume":"18","author":"Tasaka","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.09.030_bib3","article-title":"Evolving epidemiology of pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany","volume":"18","author":"Kolbrink","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jiac.2023.09.030_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jiac.2023.09.030_bib5","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.chest.2020.05.558","article-title":"Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases","volume":"158","author":"Ghembaza","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2023.09.030_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2023.07.012","article-title":"A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: preventive effects of trimethoprim-sulfamethoxazole","author":"Miyake","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.09.030_bib7","article-title":"Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2023.09.030_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/03009742.2020.1850854","article-title":"Reduction of Pneumocystis jirovecii pneumonia and bloodstream infections by trimethoprim-sulfamethoxazole prophylaxis in patients with rheumatic diseases","volume":"50","author":"Honda","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jiac.2023.09.030_bib9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/rheumatology\/keab647","article-title":"Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b\/tsDMARDs: insights from 3787 cases in the FIRST registry","volume":"61","author":"Sonomoto","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jiac.2023.09.030_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/1346-8138.15724","article-title":"Adverse effects of trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis pneumonia in dermatology","volume":"48","author":"Kokubu","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.jiac.2023.09.030_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.101999","article-title":"Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: a retrospective cohort study","volume":"67","author":"Otani","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jiac.2023.09.030_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-016-1206-8","article-title":"Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial","volume":"19","author":"Utsunomiya","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jiac.2023.09.030_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.jiac.2023.09.030_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1464-410X.1985.tb06340.x","article-title":"The effect of trimethoprim on serum creatinine","volume":"57","author":"Kastrup","year":"1985","journal-title":"Br J Urol"},{"key":"10.1016\/j.jiac.2023.09.030_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/10915818211048151","article-title":"Evaluation of the expression profile of antibiotic-induced thrombocytopenia using the Japanese adverse drug event report database","volume":"40","author":"Asai","year":"2021","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.jiac.2023.09.030_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.12691\/ajmcr-9-3-6","article-title":"Acute severe thrombocytopenia event associated with trimethoprim\/sulfamethoxazole use","volume":"9","author":"Doodnauth","year":"2021","journal-title":"Am J Med Case Rep"},{"key":"10.1016\/j.jiac.2023.09.030_bib17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne","year":"2020","journal-title":"J Clin Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:40Z","timestamp":1761160000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1341321X23002404"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.030","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}